ARA -290 - 16 MG

ARA-290 (Cibinetide)

Course Target: Neurology, Chronic Pain Management, and Cellular Cytoprotection.

Core Focal Point: Innate Repair Receptor (IRR) Activation and Peripheral Neuropathy.

1. Molecular Structure & Origin

ARA-290 is a synthetic 11-amino acid peptide modeled exactly after the non-hematopoietic (non-blood forming) loop of the Erythropoietin molecule.

• The EPO Problem: Natural EPO is excellent for tissue repair, but it massively triggers red blood cell production. If a non-anemic person takes it long-term, it thickens the blood, drastically increasing the risk of strokes and heart attacks.

• The ARA-290 Solution: It is engineered to completely ignore the traditional EPO receptors. It does not alter red blood cell volume or hemoglobin levels at all, making it completely safe from blood-thickening hazards.

2. 🎯 The Cellular Mechanism: Turning Off the Alarm

To explain ARA-290 to your class, use the phrase "The Nerve Shield." It targets a very specific cellular structure that only appears when a tissue is in severe distress: the Innate Repair Receptor (IRR).

         [Nerve Damage / Tissue Injury / Severe Inflammation]
                                   │
                                   ▼
             [Innate Repair Receptor (IRR) Activates]
                                   │
                                   ▼
           [IRR Drives Chronic Neuropathic Pain & Death Signals]
                                   │
               ┌───────────────────┴───────────────────┐
               ▼ (Normal State)                        ▼ (Introduce ARA-290)
     [Cell Death & Permanent]                 [ARA-290 Binds to IRR]
         [Nerve Damage]                                │
                                                       ▼
                                          [Blocks Inflammatory Pathways]
                                                       │
                                                       ▼
                                          [Triggers Neuroprotection &]
                                            [Small Fiber Regeneration]

Step 1: The Distress Signal

When peripheral nerves are crushed, damaged by diabetes, or suffocated by inflammation, the affected cells immediately assemble a specialized survival structure called the Innate Repair Receptor (IRR).

Step 2: Neutralizing the Tissue-Damaging Switch

Once activated, the IRR sends out emergency signals that trigger severe tissue inflammation, burning pain, and cell death. ARA-290 travels through the body and binds directly and selectively to this IRR structure.

Step 3: Small Nerve Fiber Regeneration

By locking onto the IRR, ARA-290 shuts down tissue-damaging inflammatory pathways. Instead of dying, the damaged nerve cells are given the cellular signaling needed to repair their structural axons, actively regrowing small nerve fibers that were previously stripped away by disease.

3. Primary Diseases & Conditions That Benefit From ARA-290

1. Small Fiber Neuropathy (SFN)

• The Disease: A debilitating condition where the tiny, thin nerve fibers in the skin and extremities are destroyed, causing a relentless, agonizing burning, tingling, or "pins and needles" sensation.

• How ARA-290 Helps: It is a first-in-class therapeutic candidate for SFN. Clinical trials show that ARA-290 significantly regrows small nerve fibers in the skin, leading to a direct, massive reduction in chronic neuropathic pain scores.

2. Sarcoidosis

• The Disease: An inflammatory disease where the immune system forms clusters of irritated cells (granulomas) in the lungs, skin, and lymph nodes, often causing secondary neuropathic pain.

• How ARA-290 Helps: FDA-granted orphan drug designation was given to ARA-290 for this condition. It systematically cools down sarcoidosis-induced tissue damage, drastically reducing daily pain and significantly improving the overall functional quality of life for these patients.

3. Diabetic Neuropathy

• The Disease: Chronic high blood sugar damages the blood vessels feeding peripheral nerves, causing the nerves in the feet and legs to die off.

• How ARA-290 Helps: Preclinical models show that it restores normal blood flow dynamics to damaged tissues and protects diabetic nerves from metabolic oxidative stress, preventing permanent numbness and limb ulcerations.

• ARA-290 heals nerve tissue.

4. Chronic Wound Healing & Ischemic Injuries

• The Disease: Severe tissue wounds or organs that have lost their oxygen supply due to restricted blood flow (ischemia).

• How ARA-290 Helps: By stimulating the IRR pathway without altering blood viscosity, it activates local stem cells to repair tissue gaps and accelerates the safe closure of chronic, non-healing wounds.

Product Details

• Compound: ARA -290
• Quantity: 16 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture

Research Use Only

This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.

This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.

By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.